AQR Capital Management - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$705,000
-50.0%
82,897
-27.4%
0.00%
-66.7%
Q2 2015$1,411,000
+21.3%
114,139
+16.6%
0.00%0.0%
Q1 2015$1,163,000
-0.3%
97,900
-5.2%
0.00%
+50.0%
Q4 2014$1,167,000
+33.1%
103,300
+3.4%
0.00%0.0%
Q3 2014$877,00099,9000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 98,001$661,0000.71%
Tekla Capital Management LLC 537,600$3,618,0000.49%
CAMBRIDGE TRUST CO 239,003$1,611,0000.17%
FARALLON CAPITAL MANAGEMENT LLC 1,067,538$7,185,0000.14%
Asset Management Group, Inc. 29,453$199,0000.14%
Magnetar Financial LLC 754,837$5,080,0000.11%
Trellus Management Company, LLC 11,000$74,0000.09%
JAMISON EATON & WOOD INC /NJ 42,042$283,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 1,491,850$10,055,0000.07%
NORTH AMERICAN MANAGEMENT CORP 45,000$303,0000.06%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders